Yuvezzi, a combination cholinergic agonist and alpha-adrenergic agonist, is now FDA-approved as a once-daily treatment for ...
Synthetic drugs are raising the risk of an epidemic worse than that of fentanyl in the UK and Europe. Marianne Guenot explains what these drugs are and what clinicians need to know Mat Southwell had ...
Epinephrine is a commonly used agent for a variety of indications and clinical scenarios within the emergency department. It is commonly administered during cardiopulmonary arrest and serves as an ...
Alcohol use is widespread and alcohol use disorder (AUD) causes substantial harm. AUD affects 29 million individuals and ...
As the weight loss industry faces a crisis of trust, a new independent dossier has been published regarding CitrusBurn, the trending supplement currently dominating search engines for its association ...
New peer-reviewed research adds to substantial body of scientific evidence highlighting the safety of natural kratom leaf ...
A new study offers fresh hope for people living with type 2 diabetes and obesity. Researchers report progress toward a pill ...
A NEW class of oral drugs selectively targeting the β2 adrenergic receptor (β2AR) through a GRK2-biased pathway offers potential advances in the treatment of type 2 diabetes and obesity. Traditional ...
Presbyopia-correcting eye drops enhance depth of focus by constricting the pupil, using cholinergic agonists to activate the iris sphincter muscle. FDA-approved options include pilocarpine, aceclidine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results